Mirataz 2 % W/W 5 g
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
Mirataz is a transdermal administered ointment of 2% Mirtazapine for body weight gain in cats with a poor appetite and weight loss. The ointment is applied to the inner pinna of the cat's ear once a day. Early recognition and treatment of feline unintentional weight loss is critical since cats do not tolerate even short periods of inadequate nutrition. Mirataz is the first and only Veterinairy approved transdermal medication for the management of weight loss in cats.
Product Details
| DIN (Drug Identification Number) | 02504626 |
| Approved For | Cat |
| Therapeutic Use | Antidepressant |
| Form | Ointment |
| Route of Administration | Topical |
| Strength / Concentration | 2 % W/W % W/W |
| Pack Size | 5 g |
Safety & Storage
Storage: Ambient
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Dechra |
|---|---|
| DIN | 2504626 |
| Strength | 2 % W/W % W/W |
| Pack Size | 5 g |
Storage & Shipping
| Shipping Weight | 0.016 kg |
|---|---|
| Storage Conditions | Ambient |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.
